Rui Han

3.7k total citations
114 papers, 2.9k citations indexed

About

Rui Han is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rui Han has authored 114 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 39 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Rui Han's work include Lung Cancer Treatments and Mutations (28 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Metabolism, Diabetes, and Cancer (7 papers). Rui Han is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), PI3K/AKT/mTOR signaling in cancer (13 papers) and Metabolism, Diabetes, and Cancer (7 papers). Rui Han collaborates with scholars based in China, United States and Hong Kong. Rui Han's co-authors include Terry J. Smith, Yong He, Yubo Wang, Li Li, Hengyi Chen, Caiyu Lin, Shanli Tsui, William W. Cruikshank, Jane Pritchard and Qicheng Fang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Rui Han

111 papers receiving 2.8k citations

Peers

Countries citing papers authored by Rui Han

Since Specialization

Citations

This map shows the geographic impact of Rui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Han more than expected).

Fields of papers citing papers by Rui Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Han. The network helps show where Rui Han may publish in the future.

Co-authorship network of co-authors of Rui Han

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Han. A scholar is included among the top collaborators of Rui Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Han. Rui Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ppb-level fuel cell type NO2 sensor based on Nafion proton membrane and Au-Ni/CF sensitive electrode 2025 ·Sensors and Actuators B Chemical ·(unknown), (unknown), (unknown), Tong Wang, Rui Han, (unknown), Xishuang Liang, Fengmin Liu, Fangmeng Liu, Geyu Lu	4
2	Multieffect Specific Nanovesicles for Homing Resistant Tumors and Overcoming Osimertinib‐Acquired Resistance in NSCLC 2025 ·Advanced Healthcare Materials ·(unknown), Yihui Liu, Rui Han, Jie Zheng, Liping Wang, Chen Hu, (unknown), (unknown), Yimin Zhang, Caiyu Lin, Conghua Lu, (unknown), Huan Tang, Tingting He, Liling Tang, Yong He	2
3	Ag modified metal oxides (MOx) as sensing electrodes for CeO2 based mixed potential hydrogen sensors 2024 ·Sensors and Actuators B Chemical ·Tong Wang, Yue Zhang, Hanlin Wu, (unknown), Rui Han, Xishuang Liang, Fengmin Liu, Fangmeng Liu, Geyu Lu	3
4	Efficiency of Non-Invasive Prenatal Testing in Detecting Fetal Copy Number Variation: A Retrospective Cohort Study 2024 ·International Journal of Women s Health ·Li Yang, (unknown), (unknown), Rui Han, (unknown), (unknown)	0
5	Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect 2024 ·Journal for ImmunoTherapy of Cancer ·Conghua Lu, (unknown), (unknown), (unknown), Chen Hu, (unknown), (unknown), Yihui Liu, Caiyu Lin, Tao Peng, (unknown), Yimin Zhang, Fenfen Sun, (unknown), (unknown), Rui Han, Yong He	9
6	High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma 2023 ·Journal of Cancer ·Rui Han, (unknown), Min Tang, Min Li, Binbin Zhang, Guanghe Fei, Sijing Zhou, Ran Wang	2
7	Computed tomography imaging and clinical characteristics of pulmonary ground‐glass nodules ≤2 cm with micropapillary pattern 2023 ·Thoracic Cancer ·(unknown), (unknown), Xiao Li, (unknown), Hui Wang, Rui Han, (unknown), Zhen Feng, Meng Li, (unknown), Zhongmin Peng	2
8	A YSZ-based mixed potential sensor achieving fast detection and complete recovery to SO2 through combining a high-temperature pulse and Pd catalyst in sensing electrode 2023 ·Sensors and Actuators B Chemical ·Qi Lu, Rui Han, Tong Wang, Bin Wang, Xishuang Liang, Fangmeng Liu, Geyu Lu	8
9	Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial 2023 ·PubMed ·Rui Han, (unknown), Yubo Wang, (unknown), (unknown), Yong He	2
10	Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance 2023 ·Japanese Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, (unknown), (unknown), Yong He	1
11	The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer 2022 ·Cancer Medicine ·(unknown), (unknown), Yongchang Zhang, Rui Han, Yubo Wang, Li Li, Yimin Zhang, Mengxiao Zhu, (unknown), Haiwei Du, Chen Hu, Chengzhi Zhou, Nong Yang, Shangli Cai, Yong He	4
12	First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness, Resistance Mechanisms, and Prognosis of Different Subsequent Treatments 2022 ·Clinical Medicine Insights Oncology ·(unknown), (unknown), Jian Zhang, Jie Dai, Zhulin Liu, Zhenyu Ding, Yubo Wang, Mengxiao Zhu, Chen Hu, Rui Han, Huan Tang, (unknown), Yong He	6
13	Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling 2022 ·Communications Biology ·Li Li, Zhujun Li, Conghua Lu, Jianghua Li, Kejun Zhang, Caiyu Lin, Xiaolin Tang, Zhulin Liu, Yimin Zhang, Rui Han, Yubo Wang, Mingxia Feng, Yuan Zhuang, Chen Hu, Yong He	26
14	Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC 2022 ·Cell Death Discovery ·Conghua Lu, Rui Yu, Chong Zhang, Caiyu Lin, (unknown), Di Wu, (unknown), Tao Peng, Huan Tang, Rui Han, Yong He	9
15	VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy 2021 ·Carcinogenesis ·Hengyi Chen, Conghua Lu, Caiyu Lin, Li Li, Yubo Wang, Rui Han, Chen Hu, Yong He	9
16	Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1 2020 ·Cell Death and Disease ·Hengyi Chen, Caiyu Lin, Tao Peng, (unknown), Conghua Lu, Li Li, Yubo Wang, Rui Han, Mingxia Feng, Fenfen Sun, Yong He	20
17	Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways 2020 ·3 Biotech ·Yubo Wang, Caiyu Lin, Rui Han, Conghua Lu, Li Li, Chen Hu, Mingxia Feng, Hengyi Chen, Yong He	12
18	Aspirin sensitizes osimertinib‐resistant NSCLC cells in vitro and in vivo via Bim‐dependent apoptosis induction 2020 ·Molecular Oncology ·Rui Han, Shuai Hao, Conghua Lu, Chong Zhang, Caiyu Lin, Li Li, Yubo Wang, Chen Hu, Yong He	26
19	Genetic Heterogeneity Between Paired Primary and Brain Metastases in Lung Adenocarcinoma 2020 ·Clinical Medicine Insights Oncology ·Li Li, Zhulin Liu, Rui Han, Lin Li, Mengyao Wang, Depei Huang, Yong He	9
20	Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal 2014 ·Clinical Cancer Research ·Li Li, Rui Han, Hualiang Xiao, Caiyu Lin, Yubo Wang, Hao Liu, Kunlin Li, Hengyi Chen, Fenfen Sun, Zhenzhou Yang, Jianxin Jiang, Yong He	204

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact